핵의학

본문글자크기
  • 2017년 07월호
    [Leuk Lymphoma.] Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma.

    성균관의대 / 문승환 , 이아영, 이경한*

  • 출처
    Leuk Lymphoma.
  • 등재일
    2017 Jun
  • 저널이슈번호
    58(6):1341-1348. doi: 10.1080/10428194.2016.1236380. Epub 2016 Oct 9.
  • 내용

    바로가기  >

    Abstract

    Subjects were 45 patients with angioimmunoblastic T-cell lymphoma (AITL) who underwent 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) at baseline and interim after 2-4 cycles. Predictors of progression-free survival (PFS) and overall survival (OS) were assessed. Positive interim PET/CT (Deauville score ≥3) was a significant independent predictor of poor PFS (Hazard ratio, 4.42; p=.028), and showed marginal significance to predict OS (p=.065). Less than 60% decrease in the average change of maximum standardized uptake value normalized by lean body mass (SULmax) also was a significant independent predictor of poor PFS (Hazard ratio, 12.96; p=.001) and poor OS (Hazard ratio, 24.11; p=.006). Interim PET/CT has a significant prognostic value for predicting PFS and OS in patients with AITL. Deauville score and percent decrease of SULmax have the potential to be useful parameter in classifying patients into good and poor responders.

     

    Author information

    Moon SH1, Lee AY1, Kim WS2, Kim SJ2, Cho YS1, Choe YS1, Kim BT1, Lee KH1.

    1 a Departments of Nuclear Medicine and Division of Hematology-Oncology , Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , Republic of Korea.

    2 b Department of Medicine , Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , Republic of Korea. 

  • 키워드
    18F-FDG; Angioimmunoblastic T-cell lymphoma; PET/CT; prognosis​
  • 덧글달기
    덧글달기
       IP : 3.145.96.102

    등록